Skip to main navigation Skip to search Skip to main content

Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells

  • Shuyuan Yeh
  • , Yueh Chiang Hu
  • , Mujib Rahman
  • , Hui Kuan Lin
  • , Cheng Lung Hsu
  • , Huei Ju Ting
  • , Hong Yo Kang
  • , Chawnshang Chang*
  • *Corresponding author for this work
  • University of Rochester

Research output: Contribution to journalJournal Article peer-review

139 Scopus citations

Abstract

Although mutations of the breast cancer susceptibility gene 1 (BRCA1) may play important roles in breast and prostate cancers, the detailed mechanism linking the functions of BRCA1 to these two hormone-related tumors remains to be elucidated. Here, we report that BRCA1 interacts with androgen receptor (AR) and enhances AR target genes, such as p21((WAF1)/(CIP1)), that may result in the increase of androgen-induced cell death in prostate cancer cells. The BRCA1-enhanced AR transactivation can be further induced synergistically with AR coregulators, such as CBP, ARA55, and ARA70. Together, these data suggest that the BRCA1 may function as an AR coregulator and play positive roles in androgen-induced cell death in prostate cancer cells and other androgen/AR target organs.

Original languageEnglish
Pages (from-to)11256-11261
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume97
Issue number21
DOIs
StatePublished - 10 10 2000
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells'. Together they form a unique fingerprint.

Cite this